Diphenhydramine, Sodium Bicarbonate, or Combination for Acute Peripheral Vertigo
JAMA Network Open · 2025
DOI: 10.1001/jamanetworkopen.2025.41472 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift JAMA Network Open, 2025. Verfasst von Chien-Yu Chi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Medicine, National Taiwan University Hospital Yunlin Branch, Douliu, Taiwan. Hauptthemen laut MEDLINE: Diphenhydramine, Sodium Bicarbonate, Vertigo. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Importance Intravenous diphenhydramine is commonly used to treat acute peripheral vertigo but may cause sedation. Sodium bicarbonate, an alternative therapy used in Eastern countries, may relieve vertigo symptoms without lethargy. However, comparative evidence is limited.
Objective
To evaluate the efficacy and safety of diphenhydramine, sodium bicarbonate, and their combination in treating acute peripheral vertigo among emergency department (ED) patients. Design, Setting, and Participants A triple-arm, double-blind, randomized clinical trial was conducted at the National Taiwan University Hospital, Yunlin Branch ED, from January 17 to November 14, 2023. Adults with peripheral vertigo within 24 hours of onset were enrolled. Exclusion criteria included refusal, pregnancy, prior antivertigo medication use, symptom duration of more than 24 hours, heart failure, chronic kidney disease, or drug allergy.
Interventions
Patients were randomized in a 1:1:1 ratio to receive 30 mg of intravenous diphenhydramine (group A), 66.4 mEq (approximately 1 mEq/kg) of sodium bicarbonate (group B), or both agents (group C). Main Outcomes and Measures The primary outcome was change in vertigo severity using a 10-point visual analog scale (VAS) at 60 minutes after treatment. Key secondary outcomes included change in nausea severity using a 10-point VAS, rescue medication use, ED length of stay, and adverse effects. Analysis was performed on a modified intention-to-treat basis.
Results
Among 222 patients (mean [SD] age, 57.9 [17.6] years; 150 women [67.6%]), group C had greater improvement in vertigo severity than group A (mean [SD] VAS score, –5.6 [2.1] vs –4.4 [2.7]; P = .01), with the treatment effect most pronounced among younger male patients without a history of vertigo. Group B showed similar VAS improvement compared with group A (mean [SD] VAS score, –5.1 [2.2] vs –4.4 [2.7]; P = .34). Rescue therapy was used less frequently in group C (17.8% [13 of 73]) than in group A (46.7% [35 of 75]; P < .001). No differences were observed between groups in nausea scores or ED length of stay. Lethargy was more common in diphenhydramine groups than in the sodium bicarbonate group (moderate lethargy: group A, 38.7% [29 of 75] and group C, 30.1% [22 of 73] vs group B, 8.1% [6 of 74]; P < .001). Injection discomfort was more common with sodium bicarbonate (group A, 8.0% [6 of 75]; group B, 17.6% [13 of 74]; group C, 28.8% [21 of 73]; P = .004). Conclusions and Relevance In this randomized clinical trial of patients with acute peripheral vertigo, combination therapy provided better symptom relief than diphenhydramine alone. Further studies should focus on the determination of peripheral vertigo types that can benefit from sodium bicarbonate and the underlying mechanisms. Trial Registration ClinicalTrials.gov Identifier: NCT05676216
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Emergency Medicine, National Taiwan University Hospital Yunlin Branch, Douliu, Taiwan.
- Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
- Department of Emergency Medicine, National Taiwan University Hospital and College of Medicine, Taipei, Taiwan.
- Department of Neurology, National Taiwan University Hospital Yunlin Branch, Douliu, Taiwan.
Zitieren
APA
Chi, C. Y., Chen, Y. C., Cheng, M. T., Chang, K. C., Chen, Y. P., Tsai, M. S., Chang, W. T., Ma, M. H., Huang, C. H., & Chiang, W. C. (2025). Diphenhydramine, Sodium Bicarbonate, or Combination for Acute Peripheral Vertigo. JAMA Network Open. https://doi.org/10.1001/jamanetworkopen.2025.41472
Vancouver
Chi CY, Chen YC, Cheng MT, Chang KC, Chen YP, Tsai MS, et al. Diphenhydramine, Sodium Bicarbonate, or Combination for Acute Peripheral Vertigo. JAMA Network Open. 2025. doi:10.1001/jamanetworkopen.2025.41472
BibTeX
@article{Chi2025,
author = {Chi, Chien-Yu and Chen, Yun-Chang and Cheng, Ming-Tai and Chang, Kai-Chieh and Chen, Yen-Pin and Tsai, Min-Shan and Chang, Wei-Tien and Ma, Matthew Huei-Ming and Huang, Chien-Hua and Chiang, Wen-Chu},
title = {Diphenhydramine, Sodium Bicarbonate, or Combination for Acute Peripheral Vertigo},
journal = {JAMA Network Open},
year = {2025},
doi = {10.1001/jamanetworkopen.2025.41472}
}
EUVIMED